EUIPO trademark

IMMUNOONE

RegisteredEUIPOWord markClass 5Class 42Class 44

"IMMUNOONE" is a word mark owned by OncoOne Research & Development GmbH, filed at the EUIPO on June 24, 2022. It is registered and covers classes 5, 42 and 44.

View OncoOne Research & Development GmbH portfolioGet this data via the API
Official EUIPO record
IMMUNOONE
Word mark as filed with the EUIPO
Status
Registered
Since November 11, 2022
Filed
June 24, 2022
Registered
November 10, 2022
Expires
June 24, 2032
Application no.
018722437
Registration no.
018722437
Office
EUIPO
European Union Intellectual Property Office
Mark type
Word mark
3 classes
Ownership

Who owns IMMUNOONE

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

OncoOne Research & Development GmbH

11 trademarks in the portfolioView company

Representative

Gerda Redl

Goods and services

What the mark covers

The products and services IMMUNOONE is filed for, grouped by Nice class.

  • Pharmaceutical, medical and veterinary preparations; pharmaceutical, medical and veterinary preparations comprising antibodies, antibody derivatives, and antigen binding fragments for the treatment and prevention of diseases

  • Scientific and technological services and research; scientific and technological services and research for the treatment and prevention of diseases using antibodies, antibody derivatives, and antigen binding fragments; Analytical and research services; analytical and research services for the treatment and prevention of disease using antibodies, antibody derivatives, and antigen binding fragments; pharmaceutical and biotechnological research and development; biotechnological research services

  • Medical and veterinary services, namely services for the treatment and prevention of diseases using antibodies, antibody derivatives, and antigen binding fragments

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Bulletin 2023/023 Section C.3.6
  2. Bulletin 2022/214 Section B.1
  3. Bulletin 2022/144 Section A.1
FAQ

About IMMUNOONE

Who owns the trademark "IMMUNOONE"?

The EUIPO trademark "IMMUNOONE" (application 018722437) is owned by OncoOne Research & Development GmbH.

What is the status of "IMMUNOONE"?

Its status at the EUIPO is: registered.

When was "IMMUNOONE" registered?

It was registered on November 10, 2022 and is due to expire on June 24, 2032.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull IMMUNOONE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d43ff-4203-70b1-a8bf-cada516fade3
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d43ff-4203-70b1-a8bf-cada516fade3",
  "object": "trademark",
  "mark_text": "IMMUNOONE",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "EM",
  "application_number": "018722437",
  "filing_date": "2022-06-24",
  "nice_classes": [
    5,
    42,
    44
  ],
  "owners": [
    {
      "name": "OncoOne Research & Development GmbH",
      "entity_id": "ent_019ebb33-757b-71ba-8760-99369d1f7b62"
    }
  ]
}